Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA
Primary Purpose
Osteoarthritis: Shoulder
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Interscalene brachial plexus block
bupivacaine extended-release liposome injection
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis: Shoulder
Eligibility Criteria
Inclusion Criteria:
1. All individuals undergoing primary reverse and total shoulder arthroplasty by the shoulder service at Methodist Hospital or Rothman Specialty Hospital.
Exclusion Criteria:
- Psychiatric illness as defined by co-morbid diagnosis of bipolar disorder or schizophrenia
- Revision arthroplasty, arthroplasty for fracture
- Unable/unwilling to consent for enrollment
- Unable to complete postoperative pain survey
- Known adverse drug reaction or allergy to the medications used
- Chronic pain syndromes (including reflex sympathetic dystrophy, fibromyalgia, chronic diffuse musculoskeletal pain)
- Patients taking long acting narcotic pain medications (including extended release narcotic pain medications and methadone).
- Patients under the age of 18 years
- Patients with history of hepatic disease
- Pregnant women or women who are breastfeeding
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
interscalene brachial plexus block
Bupivacaine extended-release liposome injection
Arm Description
Direct interscalene nerve block injection via brachial plexus
Infiltration of local anesthetic/analgesic, Bupivacaine extended-release liposome injection (Exparel) + Diluted in 40cc of Saline into the capsule, subscapularis, deltoid, pectoralis major and subcutaneous tissues.
Outcomes
Primary Outcome Measures
Morphine and Morphine Equivalent consumption
Secondary Outcome Measures
Full Information
NCT ID
NCT02695758
First Posted
February 22, 2016
Last Updated
February 24, 2016
Sponsor
Rothman Institute Orthopaedics
1. Study Identification
Unique Protocol Identification Number
NCT02695758
Brief Title
Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA
Official Title
Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing Shoulder Arthroplasty (TSA): A Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
December 2014 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Rothman Institute Orthopaedics
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
A non-blinded randomized controlled trial, in which participants undergoing primary reverse or total shoulder arthroplasty are randomly assigned to one of two treatment groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis: Shoulder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
156 (Actual)
8. Arms, Groups, and Interventions
Arm Title
interscalene brachial plexus block
Arm Type
Active Comparator
Arm Description
Direct interscalene nerve block injection via brachial plexus
Arm Title
Bupivacaine extended-release liposome injection
Arm Type
Active Comparator
Arm Description
Infiltration of local anesthetic/analgesic, Bupivacaine extended-release liposome injection (Exparel) + Diluted in 40cc of Saline into the capsule, subscapularis, deltoid, pectoralis major and subcutaneous tissues.
Intervention Type
Procedure
Intervention Name(s)
Interscalene brachial plexus block
Intervention Type
Procedure
Intervention Name(s)
bupivacaine extended-release liposome injection
Primary Outcome Measure Information:
Title
Morphine and Morphine Equivalent consumption
Time Frame
24 hours following surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
1. All individuals undergoing primary reverse and total shoulder arthroplasty by the shoulder service at Methodist Hospital or Rothman Specialty Hospital.
Exclusion Criteria:
Psychiatric illness as defined by co-morbid diagnosis of bipolar disorder or schizophrenia
Revision arthroplasty, arthroplasty for fracture
Unable/unwilling to consent for enrollment
Unable to complete postoperative pain survey
Known adverse drug reaction or allergy to the medications used
Chronic pain syndromes (including reflex sympathetic dystrophy, fibromyalgia, chronic diffuse musculoskeletal pain)
Patients taking long acting narcotic pain medications (including extended release narcotic pain medications and methadone).
Patients under the age of 18 years
Patients with history of hepatic disease
Pregnant women or women who are breastfeeding
12. IPD Sharing Statement
Learn more about this trial
Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA
We'll reach out to this number within 24 hrs